GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (STU:3XV) » Definitions » PB Ratio

Xvivo Perfusion AB (STU:3XV) PB Ratio : 5.61 (As of Apr. 28, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Xvivo Perfusion AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-28), Xvivo Perfusion AB's share price is €31.50. Xvivo Perfusion AB's Book Value per Share for the quarter that ended in Mar. 2024 was €5.62. Hence, Xvivo Perfusion AB's PB Ratio of today is 5.61.

The historical rank and industry rank for Xvivo Perfusion AB's PB Ratio or its related term are showing as below:

STU:3XV' s PB Ratio Range Over the Past 10 Years
Min: 2.87   Med: 6.09   Max: 12.9
Current: 5.61

During the past 12 years, Xvivo Perfusion AB's highest PB Ratio was 12.90. The lowest was 2.87. And the median was 6.09.

STU:3XV's PB Ratio is ranked worse than
83.52% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 2.19 vs STU:3XV: 5.61

During the past 12 months, Xvivo Perfusion AB's average Book Value Per Share Growth Rate was 31.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 20.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 26.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 27.30% per year.

During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Xvivo Perfusion AB was 39.50% per year. The lowest was 17.40% per year. And the median was 28.60% per year.

Back to Basics: PB Ratio


Xvivo Perfusion AB PB Ratio Historical Data

The historical data trend for Xvivo Perfusion AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB PB Ratio Chart

Xvivo Perfusion AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 8.85 6.23 3.74 5.39

Xvivo Perfusion AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.95 5.93 4.68 5.39 4.22

Competitive Comparison of Xvivo Perfusion AB's PB Ratio

For the Medical Devices subindustry, Xvivo Perfusion AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xvivo Perfusion AB's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xvivo Perfusion AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Xvivo Perfusion AB's PB Ratio falls into.



Xvivo Perfusion AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Xvivo Perfusion AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=31.50/5.619
=5.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Xvivo Perfusion AB  (STU:3XV) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Xvivo Perfusion AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Xvivo Perfusion AB (STU:3XV) Business Description

Traded in Other Exchanges
Address
Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14
Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (STU:3XV) Headlines

No Headlines